奶牛乳房炎金黄色葡萄球菌耐药性及以黏附素为靶位的疫苗的基础研究
|
摘要
奶牛乳房炎不仅给世界乳品工业带来巨大的经济损失,而且还危害到公共卫生和人类健康。其中金黄色葡萄球菌是引起奶牛乳房炎的主要病原,由于金黄色葡萄球菌具有在乳腺细胞内定殖的能力以及对抗生素极易产生耐药性的特性,使得用抗生素治疗的效果越来越差,因此使用疫苗进行防治就成为首选。
研究表明,引起奶牛乳房炎的金黄色葡萄球菌的耐药性随地域的不同而发生显著变化。为此,本研究从内蒙古呼和浩特地区患有乳房炎的奶牛采取样本,利用常规微生物学方法,分离到60株金黄色葡萄球菌。利用K-B琼脂法,对20种抗生素进行了耐药性分析,分别为:青霉素G、氨苄西林、哌拉西林、阿莫西林、头孢氨苄、头孢噻肟、头孢他啶、头孢唑林、头孢西丁、复方新诺明、卡那霉素、庆大霉素、环丙沙星、诺氟沙星、氧氟沙星、呋喃唑酮(痢特灵)、罗红霉素、克林霉素、红霉素、万古霉素。实验结果显示,90%以上的金黄色葡萄球菌分离株耐青霉素G,即使是对G+菌有较强抑杀作用的林可胺类和大环内酯类,也出现了高达50%左右的耐药率。此外,金黄色葡萄球菌对复方新诺明(60%),呋喃唑酮(痢特灵)(60%),罗红霉素(51.67%)和氨苄西林(51.67%)也出现了较高的耐药率。
大量研究证实,金黄色葡萄球菌的黏附素识别并特异性的结合到组织以及细胞的特定分子上是感染的关键,因此阻断细菌的黏附和在粘膜表面的定殖,可能是预防感染最有效的策略。凝集因子A(ClfA)、纤连蛋白A(FnBPA)和纤连蛋白B(FnBPB)是和金黄色葡萄球菌致病性相关的重要黏附因子。凝集因子A的A区(ClfA-A)和纤维蛋白原(Fg)结合,纤连蛋白A的D区(FnBPA-D)和纤连蛋白B的D区(FnBPB-D)主要和纤维结合素(Fn)结合。本研究通过PCR扩增技术,对临床分离到的60株金黄色葡萄球菌凝集因子A的A区和纤连蛋白D区进行了特异性的扩增,结果表明所有分离株全部含有凝集因子A的基因,并且59株分离株至少含有纤连蛋白A和B中的一种,80%的菌株含有编码FnBPA-D和FnBPB-D的基因。
虽然上述三种黏附素对金黄色葡萄球菌性乳房炎的致病作用在国内外已有报道,但有关这三种黏附素进行混合免疫的研究,目前的国内外研究尚无报道。因此,本实验利用pET-32a表达载体成功表达了金黄色葡萄球菌ClfA-A(990bp) ,FnBPA和FnBBP的D片段(402bp),并通过免疫家兔对重组融合蛋白pET32-ClfA、pET32-FnBPA和pET32-FnBPB的特异性抗体产生的能力、单一抗血清抗黏附能力,以及不同黏附素抗体组合的抗黏附能力和吞噬调理水平进行了系统研究。
实验结果显示,所有经重组蛋白免疫的家兔均可以产生较高水平的特异性抗体,而且抗体均显示出较强的抑制金黄色葡萄球菌黏附到纤维蛋白原和纤维结合素的作用。而且联合免疫组(三种重组蛋白进行混合免疫)的抗黏附效果优于其它单一抗原免疫组。此外,调理吞噬实验结果显示,免疫兔全血对金黄色葡萄球菌有较强的调理作用,且混合免疫组的兔全血(含三种不同黏附素的抗体的混合物)的吞噬调理作用最强。
本研究在国内率先应用ClfA-A、FnBPA-D和FnBPB-D基因构建亚单位疫苗,并系统地开展了实验动物免疫研究,探讨了上述三种黏附素的不同免疫组合的免疫效果。
本研究将为奶牛乳房炎金黄色葡萄球菌基因工程疫苗的研制提供新的思路。
Mastitis is one of the largest production concerns in the dairy industry worldwide. Staphylococcus aureus (S.aureus) is the most common etiologic agent of mastitis in bovines and a major cause of economic losses in the dairy industry. The occurrence of bovine mastitis has serious consequences for public health. The effects of antibiotic therapy has becoming more and more worse because S.aureus has the capacity of adherence and anchorage to mammary gland epithelium and the Characteristic of easy to produce antibiotic-resistant strains. Thus, a vaccine to protect against infection would therefore be beneficial. Antimicrobial susceptibility of S.aureus isolated from bovine mastitis varies widely by region. Therefore, 60 strains S.aureus were isolated from cases of mastitis in cow herds of Inner Mongolia of China by using microbiological method. Susceptibility to ampicillin, penicillin G, amoxicillin, piperacillin , cephalexin, cephazolin, cefotaxime, ceftazidime, cefoxitin, SMZ-TMP, gentamycin, kanamycin, norfloxacin, ciprofloxacin, ofloxacin, furaxone, torlamician, roxithromycin ,clindamycin, vancomycin, determined by the K-B agar method. Antibiotic susceptibility testing showed over 90% isolates were resistant to penicillin G. Also, high level of resistance to SMZ-TMP(57.20%), furaxone(58.47%), roxithromycin(58.90%), vancomycin(53.81%) and ampicillin(47.88%) was observed among S.aureus strains.
In this study, Fn-binding region D of FnBPs and fibrinogen-binding region A of ClfA were detected by PCR from clinical strains isolated from China. The results showed 59 tested strains carried at least one fnb gene and all of 60 strains tested carried region A of clfa.80% isolated strains carried FnBPA-D and FnBPB-D.
A large number of research shows that recognizing and specifically anchoring of S.aureus adhesins to tissues and definite molecule of cell is one of the key steps in the initiation of an infection. Blocking the primary stages of S.aureus infection, specifically the bacterial adhesin to cell and the colonization of the mucosal surface, may be the most effective strategy for preventing infections. Clumping factor A (ClfA), fibronectin binding protein A (FnBPA) and fibronectin binding protein B(FnBPB) of S.aureus are important proteins involved in the pathogenesis of staphylococcal bovine mastitis which promote binding of fibrinogen and fibrin to the bacterial cell surface. ClfA contains region A that binds fibrinogen and is a target for vaccine development. Fibronectin binding proteins FnBPA and FnBPB contains the Fn-binding domain D which promote binding of fibrin.
Numerous studies have underlined the role of ClfA, FnBPA and FnBPB in the staphylococcal infectious process, but there isn’t the report on immunization effect of different immunization strategy. Thus, the region A of ClfA (ClfA-A) and region D of FnBPA(FnBPA-D) and FnBPB(FnBPB-D) of S.aureus were successfully expressed in expression vector pET-32a and detect the anti adhesiveness, specific antibody and opsonophagocytic of antiserum of the recombinant fusion protein in the present study.
The results showed that sera from recombinant adhesin-immunized rabbit were more efficient than sera from PBS immunized rabbit at inhibiting bacterial adherence and producing of specific antibody (p < 0.01). Study proved the mixture of three kinds of recomimant proteins has an advantage in assey of antiadhesion effects. Moreover, opsonophagocytic test result showed that whole blood of immuned rabbit possessed effect of eliminating S.aureus, and opsonization of the mixture of three kinds of vaccinated rabbit blood was significantly higher than the other group immuned with single antigen.
It is the first time to application ClfA-A, FnBPA-Dand FnBPB-D genes of S.aureus to construct subunit vaccine,and the systematic immune animal experiments were carried out to examine the effection of different immunization strategy in this paper.
Thus, the study will provide new breakthrough ideas for cow mastitis S.aureus genetic engineering vaccine research.
研究表明,引起奶牛乳房炎的金黄色葡萄球菌的耐药性随地域的不同而发生显著变化。为此,本研究从内蒙古呼和浩特地区患有乳房炎的奶牛采取样本,利用常规微生物学方法,分离到60株金黄色葡萄球菌。利用K-B琼脂法,对20种抗生素进行了耐药性分析,分别为:青霉素G、氨苄西林、哌拉西林、阿莫西林、头孢氨苄、头孢噻肟、头孢他啶、头孢唑林、头孢西丁、复方新诺明、卡那霉素、庆大霉素、环丙沙星、诺氟沙星、氧氟沙星、呋喃唑酮(痢特灵)、罗红霉素、克林霉素、红霉素、万古霉素。实验结果显示,90%以上的金黄色葡萄球菌分离株耐青霉素G,即使是对G+菌有较强抑杀作用的林可胺类和大环内酯类,也出现了高达50%左右的耐药率。此外,金黄色葡萄球菌对复方新诺明(60%),呋喃唑酮(痢特灵)(60%),罗红霉素(51.67%)和氨苄西林(51.67%)也出现了较高的耐药率。
大量研究证实,金黄色葡萄球菌的黏附素识别并特异性的结合到组织以及细胞的特定分子上是感染的关键,因此阻断细菌的黏附和在粘膜表面的定殖,可能是预防感染最有效的策略。凝集因子A(ClfA)、纤连蛋白A(FnBPA)和纤连蛋白B(FnBPB)是和金黄色葡萄球菌致病性相关的重要黏附因子。凝集因子A的A区(ClfA-A)和纤维蛋白原(Fg)结合,纤连蛋白A的D区(FnBPA-D)和纤连蛋白B的D区(FnBPB-D)主要和纤维结合素(Fn)结合。本研究通过PCR扩增技术,对临床分离到的60株金黄色葡萄球菌凝集因子A的A区和纤连蛋白D区进行了特异性的扩增,结果表明所有分离株全部含有凝集因子A的基因,并且59株分离株至少含有纤连蛋白A和B中的一种,80%的菌株含有编码FnBPA-D和FnBPB-D的基因。
虽然上述三种黏附素对金黄色葡萄球菌性乳房炎的致病作用在国内外已有报道,但有关这三种黏附素进行混合免疫的研究,目前的国内外研究尚无报道。因此,本实验利用pET-32a表达载体成功表达了金黄色葡萄球菌ClfA-A(990bp) ,FnBPA和FnBBP的D片段(402bp),并通过免疫家兔对重组融合蛋白pET32-ClfA、pET32-FnBPA和pET32-FnBPB的特异性抗体产生的能力、单一抗血清抗黏附能力,以及不同黏附素抗体组合的抗黏附能力和吞噬调理水平进行了系统研究。
实验结果显示,所有经重组蛋白免疫的家兔均可以产生较高水平的特异性抗体,而且抗体均显示出较强的抑制金黄色葡萄球菌黏附到纤维蛋白原和纤维结合素的作用。而且联合免疫组(三种重组蛋白进行混合免疫)的抗黏附效果优于其它单一抗原免疫组。此外,调理吞噬实验结果显示,免疫兔全血对金黄色葡萄球菌有较强的调理作用,且混合免疫组的兔全血(含三种不同黏附素的抗体的混合物)的吞噬调理作用最强。
本研究在国内率先应用ClfA-A、FnBPA-D和FnBPB-D基因构建亚单位疫苗,并系统地开展了实验动物免疫研究,探讨了上述三种黏附素的不同免疫组合的免疫效果。
本研究将为奶牛乳房炎金黄色葡萄球菌基因工程疫苗的研制提供新的思路。
Mastitis is one of the largest production concerns in the dairy industry worldwide. Staphylococcus aureus (S.aureus) is the most common etiologic agent of mastitis in bovines and a major cause of economic losses in the dairy industry. The occurrence of bovine mastitis has serious consequences for public health. The effects of antibiotic therapy has becoming more and more worse because S.aureus has the capacity of adherence and anchorage to mammary gland epithelium and the Characteristic of easy to produce antibiotic-resistant strains. Thus, a vaccine to protect against infection would therefore be beneficial. Antimicrobial susceptibility of S.aureus isolated from bovine mastitis varies widely by region. Therefore, 60 strains S.aureus were isolated from cases of mastitis in cow herds of Inner Mongolia of China by using microbiological method. Susceptibility to ampicillin, penicillin G, amoxicillin, piperacillin , cephalexin, cephazolin, cefotaxime, ceftazidime, cefoxitin, SMZ-TMP, gentamycin, kanamycin, norfloxacin, ciprofloxacin, ofloxacin, furaxone, torlamician, roxithromycin ,clindamycin, vancomycin, determined by the K-B agar method. Antibiotic susceptibility testing showed over 90% isolates were resistant to penicillin G. Also, high level of resistance to SMZ-TMP(57.20%), furaxone(58.47%), roxithromycin(58.90%), vancomycin(53.81%) and ampicillin(47.88%) was observed among S.aureus strains.
In this study, Fn-binding region D of FnBPs and fibrinogen-binding region A of ClfA were detected by PCR from clinical strains isolated from China. The results showed 59 tested strains carried at least one fnb gene and all of 60 strains tested carried region A of clfa.80% isolated strains carried FnBPA-D and FnBPB-D.
A large number of research shows that recognizing and specifically anchoring of S.aureus adhesins to tissues and definite molecule of cell is one of the key steps in the initiation of an infection. Blocking the primary stages of S.aureus infection, specifically the bacterial adhesin to cell and the colonization of the mucosal surface, may be the most effective strategy for preventing infections. Clumping factor A (ClfA), fibronectin binding protein A (FnBPA) and fibronectin binding protein B(FnBPB) of S.aureus are important proteins involved in the pathogenesis of staphylococcal bovine mastitis which promote binding of fibrinogen and fibrin to the bacterial cell surface. ClfA contains region A that binds fibrinogen and is a target for vaccine development. Fibronectin binding proteins FnBPA and FnBPB contains the Fn-binding domain D which promote binding of fibrin.
Numerous studies have underlined the role of ClfA, FnBPA and FnBPB in the staphylococcal infectious process, but there isn’t the report on immunization effect of different immunization strategy. Thus, the region A of ClfA (ClfA-A) and region D of FnBPA(FnBPA-D) and FnBPB(FnBPB-D) of S.aureus were successfully expressed in expression vector pET-32a and detect the anti adhesiveness, specific antibody and opsonophagocytic of antiserum of the recombinant fusion protein in the present study.
The results showed that sera from recombinant adhesin-immunized rabbit were more efficient than sera from PBS immunized rabbit at inhibiting bacterial adherence and producing of specific antibody (p < 0.01). Study proved the mixture of three kinds of recomimant proteins has an advantage in assey of antiadhesion effects. Moreover, opsonophagocytic test result showed that whole blood of immuned rabbit possessed effect of eliminating S.aureus, and opsonization of the mixture of three kinds of vaccinated rabbit blood was significantly higher than the other group immuned with single antigen.
It is the first time to application ClfA-A, FnBPA-Dand FnBPB-D genes of S.aureus to construct subunit vaccine,and the systematic immune animal experiments were carried out to examine the effection of different immunization strategy in this paper.
Thus, the study will provide new breakthrough ideas for cow mastitis S.aureus genetic engineering vaccine research.
引文
1 Richard G.M.Olde Riekerink, Herman W. Barkema, Stefan Veenstra, et al. Prevalence of contagious mastitis pathogens in bulk tank milk in Prince Edward Island[J]. Can Vet J. 2006, 47(6):567-572
2 Wilson DJ, Gonzalez RN, Das HH. Bovine mastitis pathogens in New York and Pennsylvania: prevalence and effects on somatic cell count and milk production[J]. J Dairy Sci, 1997,80:2592-2598
3 Barkema HW, Van der Ploeg JD, Schukken YH, Lam TJ, Benedictus G, Brand A. Management style and its association with bulk milk somatic cell count and incidence rate of clinical mastitis[J]. J Dairy Sci. 1999, 82:1655-1663
4 Piret Kalmus, Arvo Viltrop, Birgit Aasm?e and Kalle Kask.Occurrence of clinical mastitis in primiparous Estonian dairy cows in different housing conditions [J]. Acta Vet Scand, 2006, 48(1):21
5 Heringstad B,Klemetsdal G.,Ruane U J.Selection for mastitis resistence in dairy cattle:a review with focus on the situation in the Nordic countries[J].Livestock production Production Science,2000,64:95-106
6 Charls N,Dobbins J R.Mastitis losses[J].J Am Vet Med Assoc,1997,170:1129-1132
7 Jose A,Aldo C A,Horaco R,et al.Field trials of a vaccine against bovine mastitis l:evaluation in heifers[J].J Dariy Sci,1997,80:845~853
8 Denis M, Wedlock DN, Lacy-Hulbert SJ,et al.Vaccines against bovine mastitis in the New Zealand context: what is the best way forward[J].N Z Vet J, 2009,57(3):132-40
9 Bradley A J,Green M J. The potential impact of the dry period on environmental in Staphylococcus aureus isolates[J].J Med Microbiol,1998,47(4):335-340
10杨章平,王健,丁焕峰等.奶牛隐性乳房炎发生规律的研究[J],中国奶牛,1998(1):18—20
11马保臣,李建基,王春璈.奶牛急性乳腺炎病原菌的分离与鉴定[J].中国兽医杂志,2004(11):22-24.
12 Watts J L. Etiologic agents of bovine mastitis [J].Vet Mimbiol,1988.16:41
13 Nickerson SC, Owens WE, Boddie RL.Mastitis in dairy heifers:initial studies on prevalence and control[J].Journal of dairy science,1995,78(7):1607-1618
14 Aarestrup FM, Jensen NE. Prevalence and duration of intramammary infection in Danish heifers during the peripartum period [J].J Dairy Sci, 1997,80:307–312
15 Pitkala A, Haveri M, Pyorala S, et al.Bovine mastitis in Finland 2001 prevalence,distribution of bacteria, and antimicrobial resistance[J].Journal ofdairy science,2004,87(8):2433-2441
16 Kuusela P,T Vartio,M Vuento and E B Myhre.Binding sites for streptococci andstaphylococci in fibronectin[J].Infect Immun,1984,45:433-436
17 Kelleher SL, Lonnerdal B.Immunological activities associated with milk[J].Advances in nutritional research,2001,10:39-65
18蒋次升.奶牛乳腺炎[M].杭州:浙江科学技术出版社,第一版,1989
19 Nauriyal D S and Pachauri.S S.Determination enzyme N-acetyle-β-D-glucosaminidase activity for screeing dairy herds for mastitis[J].Indian Journal of Animal Sciences 1999,69(3):175
20 Galton D M,Peterson,L.G.,and Merrill,W.G.Evaluation of Udder Preparations on intramammary infections[J].J.Dairy.Sci.,1988,71:1417-1421
21 Zecconi A,Piccinini R,Fox L K.Epidemiologic study of Intramammary infections with Staphylococcus aureus during a control program in nine commercial dairy herds[J].J Am Vet Med Assoc,2003,223:684–688
22 Wilson D J,Gonzalez R N,Case K L,Garrison L L et al. Comparison of seven antibiotic treatments with no treatment for bacteriological efficacy against bovine mastitis pathogens[J].J Dairy Sci,1999,82:1664-1670
23 Dosogne H, Vangroenweghe F, Burvenich C. Potential mechanism of action of J5 vaccine in protection against severe bovine coliform mastitis[J].Vet Res, 2002,33:1–12
24 Hogan J S,Weiss W P,Todhunter D A, Smith K L,Schoenberger P S. Efficacy of an Escherichia coli J5 mastitis vaccine in an experimental challenge trial [J]. J Dairy Sci,1992,75:415–422
25 Tomita G M,Ray C H,Nickerson S C,Owens W E,Gallo G F. A comparison of two commercially available Escherichia coli J5 vaccines against E.coli intramammary challenge[J].J Dairy Sci, 2000,83:2276–2281
26 Tenhagen B A,Edinger D,Baumgartner B,Kalbe P,Klunder G,Heuwieser W. Efficacy of a herd-specific vaccine against Staphylococcus aureus to prevent post-partum mastitis in dairy heifers[J]. J Vet Med A Physiol Pathol Clin Med, 2001,48: 601–607
27 Sharma N K, Catherine E D R, Dodd C E R. Development of a single-reaction multiplex PCR toxin typing assay for Staphylococcus aureus strains [J]. Appl Environ Microbiol. 2000,66:1347-1353
28 Talbot B G, Lacasse P. Progress in the Development of Mastitis Vaccines [J]. Livestock Production Science, 2005, 98(1/2):101-113
29 Bhanu Sinha, Martin Fraunholz. Staphylococcus aureus host cell invasion and post-invasion events [J].International Journal of Medical Microbiology, 2010, 300, (2-3):170-175
30 Christian Garzoni, William L. Kelley. Staphylococcus aureus: new evidence forintracellular persistence. Trends in Microbiology, 2009, 17(2):59-65
31 Scarpa M, Piccinini R, Brun P, Relationship between virulence factor genes in bovine Staphylococcus aureus subclinical mastitis isolates and binding to anti-adhesin antibodies [J]. J Dairy Res,2009, 24:1-9
32 Zhou Hong, Xiong Zheng-Ying,Li Han-Ping. An Iimmunogenicity Study of a Newly Fusion Protein Cna-FnBP vaccinated against Staphylococcus aureus Infections in a Mice Model[J]. Vaccine, 2006, 24(22):4830-4837
33 Hussain M, Haggar A, Peters G, et al. More than One Tandem Repeat Domain of the Extracellular Adherence Protein of Staphylococcus aureus Is Required for Aggregation, Adherence, and Host Cell Invasion but Not for Leukocyte Activation [J]. Infect Immun, 2008, 76(12): 5615–5623
34 Lulzim Shkreta, Brian G. Talbot,Moussa S. Diarra and Pierre Lacasse. Immune responses to a DNA/protein vaccination strategy against Staphylococcus aureus induced mastitis in dairy cows[J].Vaccine, 2004, 23: 114–126
35 Paape MJ, Wergin WP, Guidry AJ, et al. Leukocytes-second line of defense against invading mastitis pathogens [J]. J Dairy Sci, 1979, 62: 135-153
36 Foster TJ. Immune Evasion by Staphylococci [J]. Nat Rev Microbiol, 2005, 3(12): 948-958
37 Foster TJ, McDevitt D. Surface-associated proteins of Staphylococcus aureu: their possible roles in virulence [J]. FEMS Microbiol Letters, 1994, 118:199-205
38 Marrack P, Kappler J. The staphylococcal enterotoxins and their relatives [J]. Science, 1990, 248:705-11
39 Gilbert I. Dissociation in an encapsulated staphylococcus [J]. J Bacteriol, 1931, 21(3):157-160
40 Melly M, Duke L, Liau D F, et al. 1974. Biological properties of the encapsulated Staphylococcus aureus M. Infect. Immun. 10:389-397
41 Tuchscherr LP, Buzzola FR, Alvarez LP, et al. Antibodies to capsular polysaccharide and clumping factor A prevent mastitis and the emergence of unencapsulated and small-colony variants of Staphylococcus aureus in mice [J]. Infect Immun, 2008, 76(12):5738-44
42 Bergdoll, M S. Enterotoxins. In: Easmon C S F, Adlam C. , editors. Staphylococci and staphylococcal infections[M]. N.Y: Academic Press, Inc. 1983,559–598
43 Betley M J, Mekalanos J J. Nucleotide sequence of the type A staphylococcal enterotoxin gene. J Bacteriol, 1987, 170:34–41
44 Monday S R, Bohach G A. Use of multiplex PCR to detect classical and newly describedpyrogenic toxin genes in staphylococcal isolates[J]. J Clin Microbiol, 1999, 37:3411–3414
45 Munson S H, Tremaine M T, Betley M J, Welch R A. Identification and characterization of staphylococcal enterotoxin types G and I from Staphylococcus aureus[J]. Infect Immun, 1998, 66:3337–3348
46 Su Y C, Wong A C L. Production of staphylococcal enterotoxin H under controlled pH and aeration[J]. Int J Food Microbiol, 1998,39:87–91
47 Zhang S, Iandolo J J, Stewart G C. The enterotoxin D plasmid of Staphylococcus aureus encodes a second enterotoxin determinant (sej). FEMS Microbiol Lett. 1998,168:227–233
48 Dinges M M, Orwin P M, Schlievert P M. Enterotoxins of Staphylococcus aureus[J]. Clin Microbiol Rev, 2000, 13:16-34
49 Bergdoll M S, Crass B A, Reiser R F, Robbins R N, Davis J P. A new staphylococcal enterotoxin, enterotoxin F, associated with toxic shock-syndrome Staphylococcus aureus isolates[J]. Lancet. 1981, I:1017-1021
50 Schlievert P M, Shands K N, Dan B B, Schmid G P, Nishimura R D. Identification and characterization of an exotoxin from Staphylococcus aureus associated with toxic-shock syndrome[J].J Infect Dis, 1981, 143:509-516
51 Blomster-Hautamaa D A, Kreiswirth B N, Kornblum J S, Novick R P, Schlievert P M. The nucleotide and partial amino acid sequence of toxic shock syndrome toxin-1[J]. J Biol Chem, 1986,261:15783-15786
52 Marrack P, Kappler J. The staphylococcal enterotoxins and their relatives [J]. Science, 1990, 248:705-11
53 Bhakdi S, Tranum-Jensen J. Alpha-toxin of Staphylococcus aureus [J]. Microbiol Rev, 1991,55:733-51
54 Walev I, Reske K, Palmer M, Valeva A, Bhakdi S. Potassium-inhibited processing of IL-1b in human monocytes [J]. EMBO J, 1995,14:1607-14
55金宁一,胡仲明,冯书章.新编人兽共患病学[M].北京:科学出版社,2007:577-599
56 Middleton JR. Staphylococcus aureus antigens and challenges in vaccine development [J]. Expert Rev Vaccines, 2008,7(6):805-15
57 Kauf AC, Vinyard BT, Bannerman DD. Effect of intramammary infusion of bacterial lipopolysaccharide on experimentally induced Staphylococcus aureus intramammary infection [J]. Res Vet Sci, 2007 82(1):39-46
58 Pellegrino M, Giraudo J, Raspanti C, Nagel R, Odierno L, Primo V, Bogni C. Experimental trial in heifers vaccinated with Staphylococcus aureus avirulentmutant against bovine mastitis [J]. Vet Microbiol, 2008, 27(1-2):186-90
59 Foster T J, Hook M. Surface protein adhesins of Staphylococcus aureus [J]. Trends Microbiol, 1998, 6(12):484–488
60 Adel N.M. Nour El-Din, Lulzim Shkreta, Brian G. Talbot, Moussa S. Diarra, Pierre Lacasse. DNA immunization of dairy cows with the clumping factor A of Staphylococcus aureus [J], Vaccine, 2006, 24 (12):1997-2006
61 Jonsson K, Signas C, Muller HP, Lindberg M. Two different genes encode fibronectin binding proteins in Staphylococcus aureus. The complete nucleotide sequence and characterization of the second gene [J]. Eur J Biochem, 1991,202(3):1041-8
62 Kussela P. fibronectin binds to Staphylococcus aureus [J]. Nature (London), 1978, 276:718-720
63 Eoghan O'Neill,Clarissa Pozzi,Patrick Houston, Hilary Humphreys et al. A Novel Staphylococcus aureus Biofilm Phenotype Mediated by the Fibronectin-Binding Proteins, FnBPA and FnBPB [J]. J Bacteriol,2008,190(11): 3835–3850
64 Muzaffar Hussain, Axana Haggar, Georg Peters, et al. More than One Tandem Repeat Domain of the Extracellular Adherence Protein of Staphylococcus aureus Is Required for Aggregation, Adherence, and Host Cell Invasion but Not for Leukocyte Activation [J] Infect Immun, 2008, 76(12): 5615–5623
65 Lionel Piroth, Yok-Ai Que, Eleonora Widmer, et al. The Fibrinogen- and Fibronectin-Binding Domains of Staphylococcus aureus Fibronectin-Binding Protein A Synergistically Promote Endothelial Invasion and Experimental Endocarditis [J].Infect Immun, 2008,76(8): 3824–3831
66 Rozalska B and T Wadstr?m. Protective opsonic activity of anti-bodies against fibronectin-binding proteins (FnBPs) of Staphylococcus aureus. Scand. J Immunol, 1993, 37:575-580
67 Peacock S J, T J Foster, B J Cameron and A R Berendt. Bacterial fibronectin-binding proteins and endothelial cell surface fibronectin mediate adherence of Staphylococcus aureus to resting human endothelial cells [J]. Microbiology, 1999. 145:3477-3486
68 Sinha B, P P Fran?ois, O Nüsse, M Foti, O M. Hartford, P Vaudaux, et al. Fibronectin-binding protein acts as Staphylococcus aureus invasin via fibronectin bridging to integrinα5β1 [J]. Cell Microbiol, 1999,1:101-117
69 Gillaspy AF, Patti JM, Pratt FL Jr. The Staphylococcus aureus collagen adhesin-encoding gene (cna) is within a discrete genetic element [J]. Gene, 1997, 196(1-2):239-248
70 Denis M, Wedlock D N, Lacy-Hulbert S J, et al. Vaccines against bovine mastitis in the New Zealand context: what is the best way forward [J]. N Z Vet J, 2009, 57(3):132-40
71 Taverna F, Negri A, Piccinini R, et al. Characterization of cell wall associated proteins of a Staphylococcus aureus isolated from bovine mastitis case by a proteomic approach [J]. Vet Microbiol, 2007, 119(2-4):240-7
72 Albert Guidry, Ali Fattom, Atul Pate. Prevalence of Capsular Serotypes among Staphylococcus aureus Isolates from Cows with Mastitis in the United States[J]. Veterinary Microbiology, 1997, 59(1):53-58
73 Guidry A, Fattom A, Patel A. Serotyping Scheme for Staphylococcus aureus Isolated from Cows with Mastitis [J]. Am J Vet Res, 1998, 59(12):1537-1539
74 Lee J W, O'Brien C N,Guidery A J,et al. Effect of a trivalent vaccine against Staphylococcus aureus mastitis lymphocyte subpopulations,antibody production, and neutrophil phagocytosis[J].Canadian journal of veterinary research, 2005, 69(1): 11-18
75 Eric Brouillette, Pierre Lacasse, Lulzim Shkreta, et al.DNA immunization against the clumping factor A (ClfA) of Staphylococcus aureus [J]. Vaccine, 20(2002): 2348–2357
76 Hall A E, Domanski P J, Pratiksha R. Characterization of a protective monoclonal antibody recognizing Staphylococcus aureus MSCRAMM protein clumping factor A[J ]. Infect Immun, 2003, 71 :6864-6870
77 Rennermalm A, Li YH,Bohaufs L, et al. Antibodies against a truncated Staphylococcus aureus fibronectin-binding protein protect against dissemination of infection in the rat[J].Vaccine,2001,19(25-26):3376-3383
78 Aart L, Piet J M, Nuutenl.The Fibroneetin Binding Proteins of Staphylococcus aureus Are Requiredand Invasion of Bovine Mammary Gland Cells[J]. FEMS Microbiology Lettres, 1999, 1(180):103-109
79 Castagliuolo I, Piccinini R, Beggiao E. Mucosal Genetic Immunization against Four Adhesins Protects against Staphylococcus aureus-induced Mastitis in Mice[J]. Vaccine, 2006, 24(20):4393-4402
80 Perez-Casal J, Prysliak T, Kerro-Dego O. Immune responses to staphylococcus aureus GapC/B chimera and its potential use as a component of a vaccine for s.aureus Mastitis [J]. Vet Immunol Immunopathol, 2006, 109 (1/2):85-97
81 .Prenafeta A, March R, Foix A, Casals I, Costa L. Study of the humoral immunological response after vaccination with a Staphylococcus aureus biofilm-embedded bacterinin dairy cows: Possible role of the exopolysaccharide specific antibody production in the protection from Staphylococcus aureus induced mastitis [J]. Vet Immunol Immunopathol, 2009,24
82 Kerro-Dego O, Prysliak T, Potter A A. DNA-protein Immunization against the GapB and GapC Proteins of a Mastitis Isolate of Staphylococcus aureus [J]. Veterinary Immunology and Immunopathology, 2006, 113 (1/2):125-138
83 Middleton JR. Staphylococcus aureus antigens and challenges in vaccine development [J]. Expert Rev Vaccines, 2008, 7(6):805-15
84 Middleton JR, Luby CD, Adams DS. Efficacy of vaccination against staphylococcal mastitis: a review and new data [J]. Vet Microbiol, 2009, 134(1-2):192-198
85 Lammers A,Nuijten PJM,Kruijt E,Stockhofe-Zurwieden N,Vecht U,Smith HE, et al.Cell tropism of Staphylococcus aureus in bovine mammary gland cell cultures [J].Vet Microbiol, 1999, 67:77–89
86 Kerro Dego O,van Dijk J, Nederbragt H. Factors involved in the early pathogens is of bovine Staphylococcus aureus mastitis with emphasison bacterial adhesion and invasion.A review.VetQ 2002;24:181–98
87 Peacock SJ, Moore CE, Justice A, Kantzanou M, Story L, Mackie K, et al.Virulent combinations of adhesion and toxin genes in natural populations of Staphylococcus aureus [J].Infect Immun, 2002, 70:4987–96.
88 Patti JM, Allen BL, McGavin MJ, Hook M. Mscramm-mediated adherence of micro organisms to host tissues [J]. Ann Rev Microbiol, 1994, 48:585–617
89 Lammers A, Nuijten JM, Smith HE. The?bronectin binding proteins of Staphylococcus aureus are required for adhesion to and invasion of bovine mammary gland cells [J].FEMS Microbiol Lett, 1999, 180:103–109
90 Visai L, Xu Y, Casolini F, Rindi S, Hook M, Speziale P. Monoconal antibodies to CNA,acollagen-binding microbial surface component recognizing adhesive matrix molecules, detach Stapylococcus aureus from a collagen substrate [J]. J Biol Chem, 2000, 275:39837–45
91 Leitner G, Krifucks O, Glikman A, Younis A, Saran A. Staphylococcus aureus strains isolated from bovine mastitis: virulence, antibody production and protection from challenge in a mouse model.FEMS Immunol Med Microbiol, 2003, 35:99–106
92 Suvi Taponen, Satu Py?r?l?, Coagulase-negative staphylococci as cause of bovine mastitis—Not so different from Staphylococcus aureus [J], Vet Microbiol, 2009, 134(1-2):29-36
93 Carter EW, Kerr DE. Optimization of DNA-based vaccination in cows using green?uorescent protein and protein A as a prelude to immunization against staphylococcal mastitis [J]. J Dairy Sci, 2003, 86:1177–86
94 Mamo W, Boden M, Flock JI. Vaccination with Staphylococcus aureus ?brinogen-binding proteins(FgBPs) reduces colonization of Staphylococcus aureus in a mouse mastitis model [J].FEMS Immunol Med Microbiol, 1994, 10:47–53
95 Olmsted SB, Norcross NL. Effect of speci?c antibody on adherence of Staphylococcus aureus to bovine mammary epithelial cells. Infect Immun, 1992, 60:249–256
96 Lee JC. An experimental vaccine that targets staphylococcal virulence [J].Trends Microbiol, 1998, 6:461–463
97 Melchior MB, Van Osch MHJ, Graat RM, et al. Biofilm formation and genotyping of Staphylococcus aureus bovine mastitis isolates: Evidence for lack of penicillin-resistance in Agr-type II strains [J].Vet Microbiol, 2009, 137(1-2): 83-89
98 Zecconi A, Binda E, Borromeo V, Piccinini R. Relationshi pbetween some Staphylococcus aureus pathogenic factors and growth rates or somatic cell counts [J]. J Dairy Res, 2005, 72:203–8
99 Castagliuolo I, Sardina M, Brun P, DeRos C, Mastrotto C, Lovato L, et al. Clostridium dif?cile toxin A carboxyl-terminus peptide lacking ADP-ribosyl transferase activity acts as a mucosal adjuvant [J]. Infect Immun, 2004, 72:2827–36
100 Chandler RL. Experimental bacterial mastitis in the mouse [J]. J Med Microbiol, 1970, 3:273–80
101 Zavizion B, vanDuffelen M, Schaeffer W, Politis I. Establishment and characterization of a bovine mammary epithelial cell line with unique properties [J]. In Vitro Cell Dev Biol Anim, 1996, 32:138–48
102 Silva Holtfreter, Julia Kolata, Barbara M. Br?ker. Towards the immune proteome of Staphylococcus aureus---The anti-S. aureus antibody response [J].International Journal of Medical Microbiology, 2010,300(2-3):176-192
103 Owens WE, CH Ray, JL Watts, RJ Yancey. Comparison of success of antibiotic therapy during lactation and results of antimicrobial susceptibility tests for bovine mastitis [J]. J Dairy Sci, 1997, 80:313–317
104 Aarestrup F M, F Bager, NE Jensen, M Madsen, A Meyling, HC Wegener. Resistance to antimicrobial agents used for animal therapy in pathogenic, zoonotic and indicator bacteria isolated from different food animals in Denmark: A baseline study for the Danish Integrated Antimicrobial Resistance Monitoring Programme (DANMAP). APMIS, 1998, 106:745–770
105 Lange C, M Cardoso, D Senczek, S Schwarz. Molecular subtyping of Staphylococcus aureus isolates from cases of bovine mastitis in Brazil [J]. Vet Microbiol, 1999, 67:127–141
106 De Oliveira A P, JL Watts, SA Salmon, FM Aarestrup. Antimicrobial susceptibility of Staphylococcus aureus isolated from bovine mastitis in Europe and United States [J]. J Dairy Sci, 2000, 83:855–862
107 Hoblet,K.H.,G.D.Schnitkey,J.S.Arbaugh,J.S.Hogan,et al.Costs associated with selected preventive practices and with episodes of clinical mastitis in nine herds with low somatic cell counts[J].J Am Vet Med.Assoc,1999:190-196.
108冯春霞,豆卫.合理利用维生素和微量元素可降低奶牛乳房炎的发病率[J].中国草食动物,2002,(06):43-44
109赵伟,黄夺先.维生素E和硒在奶牛生产上应用研究进展[J].中国奶牛,1999(6):25—26.
110赵兴绪.奶牛乳腺炎防治[M].北京:金盾出版社,2007:66-67
111 Gill J J, Pacan J C, Carson M E, Leslie K E, Griffiths M W and Sabour P M. Efficacy and Pharmacokinetics of Bacteriophage Therapy in Treatment of Subclinical Staphylococcus aureus Mastitis in Lactating Dairy Cattle [J]. Antimicrob Agents Chemother 2006, 50(9):2912–2918
112 Makovec J A, and P L Ruegg. Antimicrobial resistance of bacteria isolated from dairy cow milk samples submitted for bacterial culture: 8,905 samples (1994-2001) [J]. J Am Vet Med. Assoc, 2003, 222:1582-1589
113 R F Rabello, C R V M Souza, R S Duarte, R M M Lopes, L M Teixeira and A C D Castro. Characterization of Staphylococcus aureus Isolates Recovered from Bovine Mastitis in Rio de Janeiro, Brazil [J]. J Dairy Sci, 2005, 88:3211-3219
114 Grave K, C Greko, L Nilsson, K Odensvik, T Mork and M Ronning. The usage of veterinary antibacterial drugs for mastitis in cattle in Norway and Sweden during 1990–1997 [J]. Prev Vet Med, 1999, 42:25–55
115 Gentilini E., Denamiel G, Llorente P, Godaly S, Rebuelto M, de Gregorio O. Antimicrobial susceptibility of Staphylococcus aureus isolated from bovine mastitis in Argentina [J]. J Dairy Sci, 2000, 83:1224-1227
116 Malinowski E, Klossowska A, Kaczmarowski M, Lassa H, Kuzma K. Antimicrobial susceptibility of staphylococci isolated from affected with mastitis cows [J]. Bull Vet Inst Pulawy, 2002, 46:289-294
117 Werckenthin C, Cardoso M, Martel J L and Schwarz S. Antimicrobial resistance in staphylococci from animals with particular reference to bovine Staphylococcus aureus, porcine Staphylococcus hyicus, and canine Staphylococcus intermedius [J].Vet Res,2001, 32:341-362
118张中文.北京地区奶牛乳腺炎病原菌的分离鉴定与药敏试验[J].北京农学院学报,2002,17(4):44-47
119叶秀娟,杜爱芳,胡松华.金华地区奶牛乳房炎病原菌的分离鉴定及药敏实验[J].黑龙江畜牧兽医, 2004(8)
120双金,嘎尔迪等.奶牛隐性乳腺炎的发生规律及其致病菌的分离鉴别与药物敏感性试验[J].内蒙古农业大学学报,2001,22(1):18-23
121 Brouillette E, Grondin G, Shkreta L, et al. In vivo and in vitro demonstration that Staphylococcus aureus is an intracellular pathogen in the presence or absence of fibronectin-binding proteins[J]. Vet Microbiol. 2004, 101(4):253-62
122 Dupuit F, D Gaillard, J Hinnrasky, E Mongodin, S de Bentzmann, E Copreni, and E Puchelle. Differentiated and functional human airway epithelium regeneration in tracheal xenografts [J]. Am J Physiol, 2000,278:L165-L176
123 Dziewanowska K, J M Patti, C F Deobald, K W Bayles, WR Trumble, and G. A. Bohach. Fibronectin binding protein and host cell tyrosine kinase are required for internalization of Staphylococcus aureus by epithelial cells [J]. Infect Immun. 1999, 67:4673-4678
124 Fowler T, E R Wann, D Joh, S Johansson, T J Foster and M H??k. Cellular invasion by Staphylococcus aureus involves a fibronectin bridge between the bacterial fibronectin-binding MSCRAMMs and host cell ?1 integrins [J]. Eur J Cell Biol, 2000, 79:672-679
125 Joh HJ, House-Pompeo K, Patti JM, et al. Fibronectin receptors from gram-positive bacteria: comparison of active sites [J]. Biochemistry, 1994, 33(20):6086-92
126 Peacock S J, Day N P, Thomas M G, Berendt A R, Foster T J. Clinical isolates of Staphylococcus aureus exhibit diversity in fnb genes and adhesion to human fibronectin [J]. J Infect,2000, 41:23–31
127 Mongodin E, O Bajolet, J Cutrona, N Bonnet, F Dupuit, E Puchelle, and S de Bentzmann. Fibronectin-binding proteins of Staphylococcus aureus are involved in adherence to human airway epithelium [J]. Infect Immun,2002, 70:620-630
128 Rice K, M Huesca, D Vaz, and M J McGavin. Variance in fibronectin binding and fnb locus polymorphisms in Staphylococcus aureus: identification of antigenic variation in a fibronectin binding protein adhesin of the epidemic CMRSA-1 strain of methicillin-resistant S. aureus [J]. Infect Immun,2001,69:3791-3799
129马保臣.奶牛乳腺炎病因学和金黄色葡萄球菌的分子调查及Fnbp蛋白免疫[D].2006
130 Matthias Grundmeier, Muzaffar Hussain, Petra Becker, Christine Heilmann, GeorgPeters, and Bhanu Sinha. Truncation of Fibronectin-Binding Proteins in Staphylococcus aureus Strain Newman Leads to Deficient Adherence and Host Cell Invasion Due to Loss of the Cell Wall Anchor Function[J]. Infection and Immunity, 2004, 72(12): 7155-7163
131 Sinha, B., P. P. Fran?ois, Y.-A. Que, M. Hussain, C. Heilmann, P. Moreillon, D. Lew, K. H. Krause, G. Peters, and M. Herrmann. Heterologously expressed Staphylococcus aureus fibronectin-binding proteins are sufficient for invasion of host cells[J]. Infect. Immun,2000, 68:6871-6878
132 Emmanuel Mongodin, Odile Bajolet, Jér?me Cutrona, No?l Bonnet, Florence Dupuit, Edith Puchelle and Sophie de Bentzmann. Fibronectin-Binding Proteins of Staphylococcus aureus Are Involved in Adherence to Human Airway Epithelium[J]. Infect Immun. 2002, 70(2): 620-630
133 Ruth C. Massey, Shobana R. Dissanayeke, Brian Cameron, David Ferguson, Timothy J. Foster, and Sharon J. Peacock. Functional Blocking of Staphylococcus aureus Adhesins following Growth in Ex Vivo Media[J]. Infection and Immunity, 2002, 70(10): 5339-5345
134 Lionel Piroth, Yok-Ai Que, Eleonora Widmer, Alexandre Panchaud, Stéphane Piu, JoséM. Entenza, and Philippe Moreillon. The Fibrinogen- and Fibronectin-Binding Domains of Staphylococcus aureus Fibronectin-Binding Protein A Synergistically Promote Endothelial Invasion and Experimental Endocarditis [J]. Infect Immun, 2008, 76(8): 3824–3831
135 Flock JI. Extracellular-matrix-binding proteins as targets for the prevention of Staphylococcus aureus infections [J]. Mol Med Today,1999,5:532–7
2 Wilson DJ, Gonzalez RN, Das HH. Bovine mastitis pathogens in New York and Pennsylvania: prevalence and effects on somatic cell count and milk production[J]. J Dairy Sci, 1997,80:2592-2598
3 Barkema HW, Van der Ploeg JD, Schukken YH, Lam TJ, Benedictus G, Brand A. Management style and its association with bulk milk somatic cell count and incidence rate of clinical mastitis[J]. J Dairy Sci. 1999, 82:1655-1663
4 Piret Kalmus, Arvo Viltrop, Birgit Aasm?e and Kalle Kask.Occurrence of clinical mastitis in primiparous Estonian dairy cows in different housing conditions [J]. Acta Vet Scand, 2006, 48(1):21
5 Heringstad B,Klemetsdal G.,Ruane U J.Selection for mastitis resistence in dairy cattle:a review with focus on the situation in the Nordic countries[J].Livestock production Production Science,2000,64:95-106
6 Charls N,Dobbins J R.Mastitis losses[J].J Am Vet Med Assoc,1997,170:1129-1132
7 Jose A,Aldo C A,Horaco R,et al.Field trials of a vaccine against bovine mastitis l:evaluation in heifers[J].J Dariy Sci,1997,80:845~853
8 Denis M, Wedlock DN, Lacy-Hulbert SJ,et al.Vaccines against bovine mastitis in the New Zealand context: what is the best way forward[J].N Z Vet J, 2009,57(3):132-40
9 Bradley A J,Green M J. The potential impact of the dry period on environmental in Staphylococcus aureus isolates[J].J Med Microbiol,1998,47(4):335-340
10杨章平,王健,丁焕峰等.奶牛隐性乳房炎发生规律的研究[J],中国奶牛,1998(1):18—20
11马保臣,李建基,王春璈.奶牛急性乳腺炎病原菌的分离与鉴定[J].中国兽医杂志,2004(11):22-24.
12 Watts J L. Etiologic agents of bovine mastitis [J].Vet Mimbiol,1988.16:41
13 Nickerson SC, Owens WE, Boddie RL.Mastitis in dairy heifers:initial studies on prevalence and control[J].Journal of dairy science,1995,78(7):1607-1618
14 Aarestrup FM, Jensen NE. Prevalence and duration of intramammary infection in Danish heifers during the peripartum period [J].J Dairy Sci, 1997,80:307–312
15 Pitkala A, Haveri M, Pyorala S, et al.Bovine mastitis in Finland 2001 prevalence,distribution of bacteria, and antimicrobial resistance[J].Journal ofdairy science,2004,87(8):2433-2441
16 Kuusela P,T Vartio,M Vuento and E B Myhre.Binding sites for streptococci andstaphylococci in fibronectin[J].Infect Immun,1984,45:433-436
17 Kelleher SL, Lonnerdal B.Immunological activities associated with milk[J].Advances in nutritional research,2001,10:39-65
18蒋次升.奶牛乳腺炎[M].杭州:浙江科学技术出版社,第一版,1989
19 Nauriyal D S and Pachauri.S S.Determination enzyme N-acetyle-β-D-glucosaminidase activity for screeing dairy herds for mastitis[J].Indian Journal of Animal Sciences 1999,69(3):175
20 Galton D M,Peterson,L.G.,and Merrill,W.G.Evaluation of Udder Preparations on intramammary infections[J].J.Dairy.Sci.,1988,71:1417-1421
21 Zecconi A,Piccinini R,Fox L K.Epidemiologic study of Intramammary infections with Staphylococcus aureus during a control program in nine commercial dairy herds[J].J Am Vet Med Assoc,2003,223:684–688
22 Wilson D J,Gonzalez R N,Case K L,Garrison L L et al. Comparison of seven antibiotic treatments with no treatment for bacteriological efficacy against bovine mastitis pathogens[J].J Dairy Sci,1999,82:1664-1670
23 Dosogne H, Vangroenweghe F, Burvenich C. Potential mechanism of action of J5 vaccine in protection against severe bovine coliform mastitis[J].Vet Res, 2002,33:1–12
24 Hogan J S,Weiss W P,Todhunter D A, Smith K L,Schoenberger P S. Efficacy of an Escherichia coli J5 mastitis vaccine in an experimental challenge trial [J]. J Dairy Sci,1992,75:415–422
25 Tomita G M,Ray C H,Nickerson S C,Owens W E,Gallo G F. A comparison of two commercially available Escherichia coli J5 vaccines against E.coli intramammary challenge[J].J Dairy Sci, 2000,83:2276–2281
26 Tenhagen B A,Edinger D,Baumgartner B,Kalbe P,Klunder G,Heuwieser W. Efficacy of a herd-specific vaccine against Staphylococcus aureus to prevent post-partum mastitis in dairy heifers[J]. J Vet Med A Physiol Pathol Clin Med, 2001,48: 601–607
27 Sharma N K, Catherine E D R, Dodd C E R. Development of a single-reaction multiplex PCR toxin typing assay for Staphylococcus aureus strains [J]. Appl Environ Microbiol. 2000,66:1347-1353
28 Talbot B G, Lacasse P. Progress in the Development of Mastitis Vaccines [J]. Livestock Production Science, 2005, 98(1/2):101-113
29 Bhanu Sinha, Martin Fraunholz. Staphylococcus aureus host cell invasion and post-invasion events [J].International Journal of Medical Microbiology, 2010, 300, (2-3):170-175
30 Christian Garzoni, William L. Kelley. Staphylococcus aureus: new evidence forintracellular persistence. Trends in Microbiology, 2009, 17(2):59-65
31 Scarpa M, Piccinini R, Brun P, Relationship between virulence factor genes in bovine Staphylococcus aureus subclinical mastitis isolates and binding to anti-adhesin antibodies [J]. J Dairy Res,2009, 24:1-9
32 Zhou Hong, Xiong Zheng-Ying,Li Han-Ping. An Iimmunogenicity Study of a Newly Fusion Protein Cna-FnBP vaccinated against Staphylococcus aureus Infections in a Mice Model[J]. Vaccine, 2006, 24(22):4830-4837
33 Hussain M, Haggar A, Peters G, et al. More than One Tandem Repeat Domain of the Extracellular Adherence Protein of Staphylococcus aureus Is Required for Aggregation, Adherence, and Host Cell Invasion but Not for Leukocyte Activation [J]. Infect Immun, 2008, 76(12): 5615–5623
34 Lulzim Shkreta, Brian G. Talbot,Moussa S. Diarra and Pierre Lacasse. Immune responses to a DNA/protein vaccination strategy against Staphylococcus aureus induced mastitis in dairy cows[J].Vaccine, 2004, 23: 114–126
35 Paape MJ, Wergin WP, Guidry AJ, et al. Leukocytes-second line of defense against invading mastitis pathogens [J]. J Dairy Sci, 1979, 62: 135-153
36 Foster TJ. Immune Evasion by Staphylococci [J]. Nat Rev Microbiol, 2005, 3(12): 948-958
37 Foster TJ, McDevitt D. Surface-associated proteins of Staphylococcus aureu: their possible roles in virulence [J]. FEMS Microbiol Letters, 1994, 118:199-205
38 Marrack P, Kappler J. The staphylococcal enterotoxins and their relatives [J]. Science, 1990, 248:705-11
39 Gilbert I. Dissociation in an encapsulated staphylococcus [J]. J Bacteriol, 1931, 21(3):157-160
40 Melly M, Duke L, Liau D F, et al. 1974. Biological properties of the encapsulated Staphylococcus aureus M. Infect. Immun. 10:389-397
41 Tuchscherr LP, Buzzola FR, Alvarez LP, et al. Antibodies to capsular polysaccharide and clumping factor A prevent mastitis and the emergence of unencapsulated and small-colony variants of Staphylococcus aureus in mice [J]. Infect Immun, 2008, 76(12):5738-44
42 Bergdoll, M S. Enterotoxins. In: Easmon C S F, Adlam C. , editors. Staphylococci and staphylococcal infections[M]. N.Y: Academic Press, Inc. 1983,559–598
43 Betley M J, Mekalanos J J. Nucleotide sequence of the type A staphylococcal enterotoxin gene. J Bacteriol, 1987, 170:34–41
44 Monday S R, Bohach G A. Use of multiplex PCR to detect classical and newly describedpyrogenic toxin genes in staphylococcal isolates[J]. J Clin Microbiol, 1999, 37:3411–3414
45 Munson S H, Tremaine M T, Betley M J, Welch R A. Identification and characterization of staphylococcal enterotoxin types G and I from Staphylococcus aureus[J]. Infect Immun, 1998, 66:3337–3348
46 Su Y C, Wong A C L. Production of staphylococcal enterotoxin H under controlled pH and aeration[J]. Int J Food Microbiol, 1998,39:87–91
47 Zhang S, Iandolo J J, Stewart G C. The enterotoxin D plasmid of Staphylococcus aureus encodes a second enterotoxin determinant (sej). FEMS Microbiol Lett. 1998,168:227–233
48 Dinges M M, Orwin P M, Schlievert P M. Enterotoxins of Staphylococcus aureus[J]. Clin Microbiol Rev, 2000, 13:16-34
49 Bergdoll M S, Crass B A, Reiser R F, Robbins R N, Davis J P. A new staphylococcal enterotoxin, enterotoxin F, associated with toxic shock-syndrome Staphylococcus aureus isolates[J]. Lancet. 1981, I:1017-1021
50 Schlievert P M, Shands K N, Dan B B, Schmid G P, Nishimura R D. Identification and characterization of an exotoxin from Staphylococcus aureus associated with toxic-shock syndrome[J].J Infect Dis, 1981, 143:509-516
51 Blomster-Hautamaa D A, Kreiswirth B N, Kornblum J S, Novick R P, Schlievert P M. The nucleotide and partial amino acid sequence of toxic shock syndrome toxin-1[J]. J Biol Chem, 1986,261:15783-15786
52 Marrack P, Kappler J. The staphylococcal enterotoxins and their relatives [J]. Science, 1990, 248:705-11
53 Bhakdi S, Tranum-Jensen J. Alpha-toxin of Staphylococcus aureus [J]. Microbiol Rev, 1991,55:733-51
54 Walev I, Reske K, Palmer M, Valeva A, Bhakdi S. Potassium-inhibited processing of IL-1b in human monocytes [J]. EMBO J, 1995,14:1607-14
55金宁一,胡仲明,冯书章.新编人兽共患病学[M].北京:科学出版社,2007:577-599
56 Middleton JR. Staphylococcus aureus antigens and challenges in vaccine development [J]. Expert Rev Vaccines, 2008,7(6):805-15
57 Kauf AC, Vinyard BT, Bannerman DD. Effect of intramammary infusion of bacterial lipopolysaccharide on experimentally induced Staphylococcus aureus intramammary infection [J]. Res Vet Sci, 2007 82(1):39-46
58 Pellegrino M, Giraudo J, Raspanti C, Nagel R, Odierno L, Primo V, Bogni C. Experimental trial in heifers vaccinated with Staphylococcus aureus avirulentmutant against bovine mastitis [J]. Vet Microbiol, 2008, 27(1-2):186-90
59 Foster T J, Hook M. Surface protein adhesins of Staphylococcus aureus [J]. Trends Microbiol, 1998, 6(12):484–488
60 Adel N.M. Nour El-Din, Lulzim Shkreta, Brian G. Talbot, Moussa S. Diarra, Pierre Lacasse. DNA immunization of dairy cows with the clumping factor A of Staphylococcus aureus [J], Vaccine, 2006, 24 (12):1997-2006
61 Jonsson K, Signas C, Muller HP, Lindberg M. Two different genes encode fibronectin binding proteins in Staphylococcus aureus. The complete nucleotide sequence and characterization of the second gene [J]. Eur J Biochem, 1991,202(3):1041-8
62 Kussela P. fibronectin binds to Staphylococcus aureus [J]. Nature (London), 1978, 276:718-720
63 Eoghan O'Neill,Clarissa Pozzi,Patrick Houston, Hilary Humphreys et al. A Novel Staphylococcus aureus Biofilm Phenotype Mediated by the Fibronectin-Binding Proteins, FnBPA and FnBPB [J]. J Bacteriol,2008,190(11): 3835–3850
64 Muzaffar Hussain, Axana Haggar, Georg Peters, et al. More than One Tandem Repeat Domain of the Extracellular Adherence Protein of Staphylococcus aureus Is Required for Aggregation, Adherence, and Host Cell Invasion but Not for Leukocyte Activation [J] Infect Immun, 2008, 76(12): 5615–5623
65 Lionel Piroth, Yok-Ai Que, Eleonora Widmer, et al. The Fibrinogen- and Fibronectin-Binding Domains of Staphylococcus aureus Fibronectin-Binding Protein A Synergistically Promote Endothelial Invasion and Experimental Endocarditis [J].Infect Immun, 2008,76(8): 3824–3831
66 Rozalska B and T Wadstr?m. Protective opsonic activity of anti-bodies against fibronectin-binding proteins (FnBPs) of Staphylococcus aureus. Scand. J Immunol, 1993, 37:575-580
67 Peacock S J, T J Foster, B J Cameron and A R Berendt. Bacterial fibronectin-binding proteins and endothelial cell surface fibronectin mediate adherence of Staphylococcus aureus to resting human endothelial cells [J]. Microbiology, 1999. 145:3477-3486
68 Sinha B, P P Fran?ois, O Nüsse, M Foti, O M. Hartford, P Vaudaux, et al. Fibronectin-binding protein acts as Staphylococcus aureus invasin via fibronectin bridging to integrinα5β1 [J]. Cell Microbiol, 1999,1:101-117
69 Gillaspy AF, Patti JM, Pratt FL Jr. The Staphylococcus aureus collagen adhesin-encoding gene (cna) is within a discrete genetic element [J]. Gene, 1997, 196(1-2):239-248
70 Denis M, Wedlock D N, Lacy-Hulbert S J, et al. Vaccines against bovine mastitis in the New Zealand context: what is the best way forward [J]. N Z Vet J, 2009, 57(3):132-40
71 Taverna F, Negri A, Piccinini R, et al. Characterization of cell wall associated proteins of a Staphylococcus aureus isolated from bovine mastitis case by a proteomic approach [J]. Vet Microbiol, 2007, 119(2-4):240-7
72 Albert Guidry, Ali Fattom, Atul Pate. Prevalence of Capsular Serotypes among Staphylococcus aureus Isolates from Cows with Mastitis in the United States[J]. Veterinary Microbiology, 1997, 59(1):53-58
73 Guidry A, Fattom A, Patel A. Serotyping Scheme for Staphylococcus aureus Isolated from Cows with Mastitis [J]. Am J Vet Res, 1998, 59(12):1537-1539
74 Lee J W, O'Brien C N,Guidery A J,et al. Effect of a trivalent vaccine against Staphylococcus aureus mastitis lymphocyte subpopulations,antibody production, and neutrophil phagocytosis[J].Canadian journal of veterinary research, 2005, 69(1): 11-18
75 Eric Brouillette, Pierre Lacasse, Lulzim Shkreta, et al.DNA immunization against the clumping factor A (ClfA) of Staphylococcus aureus [J]. Vaccine, 20(2002): 2348–2357
76 Hall A E, Domanski P J, Pratiksha R. Characterization of a protective monoclonal antibody recognizing Staphylococcus aureus MSCRAMM protein clumping factor A[J ]. Infect Immun, 2003, 71 :6864-6870
77 Rennermalm A, Li YH,Bohaufs L, et al. Antibodies against a truncated Staphylococcus aureus fibronectin-binding protein protect against dissemination of infection in the rat[J].Vaccine,2001,19(25-26):3376-3383
78 Aart L, Piet J M, Nuutenl.The Fibroneetin Binding Proteins of Staphylococcus aureus Are Requiredand Invasion of Bovine Mammary Gland Cells[J]. FEMS Microbiology Lettres, 1999, 1(180):103-109
79 Castagliuolo I, Piccinini R, Beggiao E. Mucosal Genetic Immunization against Four Adhesins Protects against Staphylococcus aureus-induced Mastitis in Mice[J]. Vaccine, 2006, 24(20):4393-4402
80 Perez-Casal J, Prysliak T, Kerro-Dego O. Immune responses to staphylococcus aureus GapC/B chimera and its potential use as a component of a vaccine for s.aureus Mastitis [J]. Vet Immunol Immunopathol, 2006, 109 (1/2):85-97
81 .Prenafeta A, March R, Foix A, Casals I, Costa L. Study of the humoral immunological response after vaccination with a Staphylococcus aureus biofilm-embedded bacterinin dairy cows: Possible role of the exopolysaccharide specific antibody production in the protection from Staphylococcus aureus induced mastitis [J]. Vet Immunol Immunopathol, 2009,24
82 Kerro-Dego O, Prysliak T, Potter A A. DNA-protein Immunization against the GapB and GapC Proteins of a Mastitis Isolate of Staphylococcus aureus [J]. Veterinary Immunology and Immunopathology, 2006, 113 (1/2):125-138
83 Middleton JR. Staphylococcus aureus antigens and challenges in vaccine development [J]. Expert Rev Vaccines, 2008, 7(6):805-15
84 Middleton JR, Luby CD, Adams DS. Efficacy of vaccination against staphylococcal mastitis: a review and new data [J]. Vet Microbiol, 2009, 134(1-2):192-198
85 Lammers A,Nuijten PJM,Kruijt E,Stockhofe-Zurwieden N,Vecht U,Smith HE, et al.Cell tropism of Staphylococcus aureus in bovine mammary gland cell cultures [J].Vet Microbiol, 1999, 67:77–89
86 Kerro Dego O,van Dijk J, Nederbragt H. Factors involved in the early pathogens is of bovine Staphylococcus aureus mastitis with emphasison bacterial adhesion and invasion.A review.VetQ 2002;24:181–98
87 Peacock SJ, Moore CE, Justice A, Kantzanou M, Story L, Mackie K, et al.Virulent combinations of adhesion and toxin genes in natural populations of Staphylococcus aureus [J].Infect Immun, 2002, 70:4987–96.
88 Patti JM, Allen BL, McGavin MJ, Hook M. Mscramm-mediated adherence of micro organisms to host tissues [J]. Ann Rev Microbiol, 1994, 48:585–617
89 Lammers A, Nuijten JM, Smith HE. The?bronectin binding proteins of Staphylococcus aureus are required for adhesion to and invasion of bovine mammary gland cells [J].FEMS Microbiol Lett, 1999, 180:103–109
90 Visai L, Xu Y, Casolini F, Rindi S, Hook M, Speziale P. Monoconal antibodies to CNA,acollagen-binding microbial surface component recognizing adhesive matrix molecules, detach Stapylococcus aureus from a collagen substrate [J]. J Biol Chem, 2000, 275:39837–45
91 Leitner G, Krifucks O, Glikman A, Younis A, Saran A. Staphylococcus aureus strains isolated from bovine mastitis: virulence, antibody production and protection from challenge in a mouse model.FEMS Immunol Med Microbiol, 2003, 35:99–106
92 Suvi Taponen, Satu Py?r?l?, Coagulase-negative staphylococci as cause of bovine mastitis—Not so different from Staphylococcus aureus [J], Vet Microbiol, 2009, 134(1-2):29-36
93 Carter EW, Kerr DE. Optimization of DNA-based vaccination in cows using green?uorescent protein and protein A as a prelude to immunization against staphylococcal mastitis [J]. J Dairy Sci, 2003, 86:1177–86
94 Mamo W, Boden M, Flock JI. Vaccination with Staphylococcus aureus ?brinogen-binding proteins(FgBPs) reduces colonization of Staphylococcus aureus in a mouse mastitis model [J].FEMS Immunol Med Microbiol, 1994, 10:47–53
95 Olmsted SB, Norcross NL. Effect of speci?c antibody on adherence of Staphylococcus aureus to bovine mammary epithelial cells. Infect Immun, 1992, 60:249–256
96 Lee JC. An experimental vaccine that targets staphylococcal virulence [J].Trends Microbiol, 1998, 6:461–463
97 Melchior MB, Van Osch MHJ, Graat RM, et al. Biofilm formation and genotyping of Staphylococcus aureus bovine mastitis isolates: Evidence for lack of penicillin-resistance in Agr-type II strains [J].Vet Microbiol, 2009, 137(1-2): 83-89
98 Zecconi A, Binda E, Borromeo V, Piccinini R. Relationshi pbetween some Staphylococcus aureus pathogenic factors and growth rates or somatic cell counts [J]. J Dairy Res, 2005, 72:203–8
99 Castagliuolo I, Sardina M, Brun P, DeRos C, Mastrotto C, Lovato L, et al. Clostridium dif?cile toxin A carboxyl-terminus peptide lacking ADP-ribosyl transferase activity acts as a mucosal adjuvant [J]. Infect Immun, 2004, 72:2827–36
100 Chandler RL. Experimental bacterial mastitis in the mouse [J]. J Med Microbiol, 1970, 3:273–80
101 Zavizion B, vanDuffelen M, Schaeffer W, Politis I. Establishment and characterization of a bovine mammary epithelial cell line with unique properties [J]. In Vitro Cell Dev Biol Anim, 1996, 32:138–48
102 Silva Holtfreter, Julia Kolata, Barbara M. Br?ker. Towards the immune proteome of Staphylococcus aureus---The anti-S. aureus antibody response [J].International Journal of Medical Microbiology, 2010,300(2-3):176-192
103 Owens WE, CH Ray, JL Watts, RJ Yancey. Comparison of success of antibiotic therapy during lactation and results of antimicrobial susceptibility tests for bovine mastitis [J]. J Dairy Sci, 1997, 80:313–317
104 Aarestrup F M, F Bager, NE Jensen, M Madsen, A Meyling, HC Wegener. Resistance to antimicrobial agents used for animal therapy in pathogenic, zoonotic and indicator bacteria isolated from different food animals in Denmark: A baseline study for the Danish Integrated Antimicrobial Resistance Monitoring Programme (DANMAP). APMIS, 1998, 106:745–770
105 Lange C, M Cardoso, D Senczek, S Schwarz. Molecular subtyping of Staphylococcus aureus isolates from cases of bovine mastitis in Brazil [J]. Vet Microbiol, 1999, 67:127–141
106 De Oliveira A P, JL Watts, SA Salmon, FM Aarestrup. Antimicrobial susceptibility of Staphylococcus aureus isolated from bovine mastitis in Europe and United States [J]. J Dairy Sci, 2000, 83:855–862
107 Hoblet,K.H.,G.D.Schnitkey,J.S.Arbaugh,J.S.Hogan,et al.Costs associated with selected preventive practices and with episodes of clinical mastitis in nine herds with low somatic cell counts[J].J Am Vet Med.Assoc,1999:190-196.
108冯春霞,豆卫.合理利用维生素和微量元素可降低奶牛乳房炎的发病率[J].中国草食动物,2002,(06):43-44
109赵伟,黄夺先.维生素E和硒在奶牛生产上应用研究进展[J].中国奶牛,1999(6):25—26.
110赵兴绪.奶牛乳腺炎防治[M].北京:金盾出版社,2007:66-67
111 Gill J J, Pacan J C, Carson M E, Leslie K E, Griffiths M W and Sabour P M. Efficacy and Pharmacokinetics of Bacteriophage Therapy in Treatment of Subclinical Staphylococcus aureus Mastitis in Lactating Dairy Cattle [J]. Antimicrob Agents Chemother 2006, 50(9):2912–2918
112 Makovec J A, and P L Ruegg. Antimicrobial resistance of bacteria isolated from dairy cow milk samples submitted for bacterial culture: 8,905 samples (1994-2001) [J]. J Am Vet Med. Assoc, 2003, 222:1582-1589
113 R F Rabello, C R V M Souza, R S Duarte, R M M Lopes, L M Teixeira and A C D Castro. Characterization of Staphylococcus aureus Isolates Recovered from Bovine Mastitis in Rio de Janeiro, Brazil [J]. J Dairy Sci, 2005, 88:3211-3219
114 Grave K, C Greko, L Nilsson, K Odensvik, T Mork and M Ronning. The usage of veterinary antibacterial drugs for mastitis in cattle in Norway and Sweden during 1990–1997 [J]. Prev Vet Med, 1999, 42:25–55
115 Gentilini E., Denamiel G, Llorente P, Godaly S, Rebuelto M, de Gregorio O. Antimicrobial susceptibility of Staphylococcus aureus isolated from bovine mastitis in Argentina [J]. J Dairy Sci, 2000, 83:1224-1227
116 Malinowski E, Klossowska A, Kaczmarowski M, Lassa H, Kuzma K. Antimicrobial susceptibility of staphylococci isolated from affected with mastitis cows [J]. Bull Vet Inst Pulawy, 2002, 46:289-294
117 Werckenthin C, Cardoso M, Martel J L and Schwarz S. Antimicrobial resistance in staphylococci from animals with particular reference to bovine Staphylococcus aureus, porcine Staphylococcus hyicus, and canine Staphylococcus intermedius [J].Vet Res,2001, 32:341-362
118张中文.北京地区奶牛乳腺炎病原菌的分离鉴定与药敏试验[J].北京农学院学报,2002,17(4):44-47
119叶秀娟,杜爱芳,胡松华.金华地区奶牛乳房炎病原菌的分离鉴定及药敏实验[J].黑龙江畜牧兽医, 2004(8)
120双金,嘎尔迪等.奶牛隐性乳腺炎的发生规律及其致病菌的分离鉴别与药物敏感性试验[J].内蒙古农业大学学报,2001,22(1):18-23
121 Brouillette E, Grondin G, Shkreta L, et al. In vivo and in vitro demonstration that Staphylococcus aureus is an intracellular pathogen in the presence or absence of fibronectin-binding proteins[J]. Vet Microbiol. 2004, 101(4):253-62
122 Dupuit F, D Gaillard, J Hinnrasky, E Mongodin, S de Bentzmann, E Copreni, and E Puchelle. Differentiated and functional human airway epithelium regeneration in tracheal xenografts [J]. Am J Physiol, 2000,278:L165-L176
123 Dziewanowska K, J M Patti, C F Deobald, K W Bayles, WR Trumble, and G. A. Bohach. Fibronectin binding protein and host cell tyrosine kinase are required for internalization of Staphylococcus aureus by epithelial cells [J]. Infect Immun. 1999, 67:4673-4678
124 Fowler T, E R Wann, D Joh, S Johansson, T J Foster and M H??k. Cellular invasion by Staphylococcus aureus involves a fibronectin bridge between the bacterial fibronectin-binding MSCRAMMs and host cell ?1 integrins [J]. Eur J Cell Biol, 2000, 79:672-679
125 Joh HJ, House-Pompeo K, Patti JM, et al. Fibronectin receptors from gram-positive bacteria: comparison of active sites [J]. Biochemistry, 1994, 33(20):6086-92
126 Peacock S J, Day N P, Thomas M G, Berendt A R, Foster T J. Clinical isolates of Staphylococcus aureus exhibit diversity in fnb genes and adhesion to human fibronectin [J]. J Infect,2000, 41:23–31
127 Mongodin E, O Bajolet, J Cutrona, N Bonnet, F Dupuit, E Puchelle, and S de Bentzmann. Fibronectin-binding proteins of Staphylococcus aureus are involved in adherence to human airway epithelium [J]. Infect Immun,2002, 70:620-630
128 Rice K, M Huesca, D Vaz, and M J McGavin. Variance in fibronectin binding and fnb locus polymorphisms in Staphylococcus aureus: identification of antigenic variation in a fibronectin binding protein adhesin of the epidemic CMRSA-1 strain of methicillin-resistant S. aureus [J]. Infect Immun,2001,69:3791-3799
129马保臣.奶牛乳腺炎病因学和金黄色葡萄球菌的分子调查及Fnbp蛋白免疫[D].2006
130 Matthias Grundmeier, Muzaffar Hussain, Petra Becker, Christine Heilmann, GeorgPeters, and Bhanu Sinha. Truncation of Fibronectin-Binding Proteins in Staphylococcus aureus Strain Newman Leads to Deficient Adherence and Host Cell Invasion Due to Loss of the Cell Wall Anchor Function[J]. Infection and Immunity, 2004, 72(12): 7155-7163
131 Sinha, B., P. P. Fran?ois, Y.-A. Que, M. Hussain, C. Heilmann, P. Moreillon, D. Lew, K. H. Krause, G. Peters, and M. Herrmann. Heterologously expressed Staphylococcus aureus fibronectin-binding proteins are sufficient for invasion of host cells[J]. Infect. Immun,2000, 68:6871-6878
132 Emmanuel Mongodin, Odile Bajolet, Jér?me Cutrona, No?l Bonnet, Florence Dupuit, Edith Puchelle and Sophie de Bentzmann. Fibronectin-Binding Proteins of Staphylococcus aureus Are Involved in Adherence to Human Airway Epithelium[J]. Infect Immun. 2002, 70(2): 620-630
133 Ruth C. Massey, Shobana R. Dissanayeke, Brian Cameron, David Ferguson, Timothy J. Foster, and Sharon J. Peacock. Functional Blocking of Staphylococcus aureus Adhesins following Growth in Ex Vivo Media[J]. Infection and Immunity, 2002, 70(10): 5339-5345
134 Lionel Piroth, Yok-Ai Que, Eleonora Widmer, Alexandre Panchaud, Stéphane Piu, JoséM. Entenza, and Philippe Moreillon. The Fibrinogen- and Fibronectin-Binding Domains of Staphylococcus aureus Fibronectin-Binding Protein A Synergistically Promote Endothelial Invasion and Experimental Endocarditis [J]. Infect Immun, 2008, 76(8): 3824–3831
135 Flock JI. Extracellular-matrix-binding proteins as targets for the prevention of Staphylococcus aureus infections [J]. Mol Med Today,1999,5:532–7